Biosynth brings breakthrough AquaSpark probe technology to ISBC 2018


Biosynth brings breakthrough AquaSpark probe technology to ISBC 2018


BioSynth 150x80

Press Release | BIOSYNTH AG

MAY 09, 2018

Staad, Switzerland: – Microbiology and organic fine biochemical CDMO and specialist supplier, Biosynth AG will be showing its latest technologies at the ISBC bioluminescence and chemiluminescence symposium in Nantes, France.

These are spearheaded by the breakthrough AquaSpark™ dioxetane chemiluminescence probes that deliver exceptional light emission properties. It will also present its novel ProLuciferines and CybLuc red shifted luciferin for cell imaging and molecular biology.

Increased chemiluminescent intensity

AquaSpark is the trademark for a suite of strongly chemiluminescent probes based on phosphatase and novel beta-galactosidase substrates developed by Ramot at Tel Aviv University in partnership with Biosynth.

AquaSpark delivers remarkable increases of chemiluminescent intensity for all four of its acrylate derivatives, up to a maximum of 3000 times those of the parent unsubstituted dioxetanes.

Lunchtime workshops Inhibitors, indicators and substrates

Biosynth will also contribute posters to the symposium and will have a dedicated booth in the exhibition zone at the La Cité Events Center in Nantes that will also highlight STAADIUM™ enzyme activated inhibitors, the RUG™ fluorogenic E. coli indicator and its popular Aldol® chromogenic, fluorogenic substrates, among its portfolio of more than 100,000 products.

“ISBC is one of the most respected meetings in our field of expertise and will give us a great platform to demonstrate our leadership in the field of chemiluminescence and bioluminescence and in manufacturing detection reagents,” commented Dr. Lukas Wick, Biosynth’s Head of R&D.

About Biosynth

The Swiss-based chemical supplier and manufacturing CDMO specializes in microbiology and organic fine chemicals in the field of bioluminescence and chemiluminescence probes, fluorescent probes, chromogenic substrates, enzyme substrates, indole derivatives and special chemicals. The company’s more than 100,000 products are widely used in microbiology, molecular biology, diagnostics, pharmaceutical industry, chemical industry, food and environmental testing.

Development projects, small and industrial scale manufacturing as well as global sourcing are all core competencies of the group, which is headquartered in Staad, Switzerland, its base for its production, sales, logistics, QA and QC, with operating subsidiaries in the USA (BIOSYNTH International, Inc, Itasca, IL) and in China (BIOSYNTH, Wuxi).

About ISBC 2018

The 20th International Symposium on Bioluminescence and Chemiluminescence (ISBC 2018) will be held under the theme ‘Living and cold light for a sustainable world’.

This annual meeting welcomes researchers from the chemiluminescence and bioluminescence communities, as well as all others using these technologies.

ISBC 2018 is a four-day event opening May 28 at La Cité, the Nantes Events Center in Brittany, Western France.

The event is organized by the International Society for Bioluminescence and Chemiluminescence, in partnership with the University of Nantes. Further information at: https://isbc-2018.sciencesconf.org/.

Media Contact

Dr. Mario Mehmel, Marketing Manager, Biosynth AG
Tel: +41 71 858 26 58
Email: Mario.mehmel@biosynth.ch

Resources

Click on Biosynth at ISBC 2018 for more information.
Click on BIOSYNTH to contact the company directly.
Click on AquaSpark™ Phosphatase Substrates for ELISA for assay information.
Click on AquaSpark™ technology for technical information.
Click on Berthold Technologies for partner information.

Traditional Dioxetane (left) vs. AquaSpark™ (right) light emission

Traditional Dioxetane (left) vs. AquaSpark™ (right) light emission


Biosynth cGMP manufacturing facilities

Biosynth cGMP manufacturing facilities


Supplier Information
Supplier: BIOSYNTH AG
Address: Rietlistr. 4, 9422 Staad, Switzerland
Tel: +41 (0)71 858 20 20
Fax: +41 (0)71 858 20 30
Website: www.biosynth.com


Comments are closed.